Risk factors for potential drug-drug interactions in patients with pneumonia.

CONCLUSION: In conclusion, community-acquired pneumonia patients with the above-mentioned factors should have their treatment more deeply monitored for pDDIs. PMID: 32990216 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32990216?dopt=Abstract

Source: International Journal of Clinical Pharmacology and Therapeutics - October 1, 2020 Category: Drugs & Pharmacology Tags: Int J Clin Pharmacol Ther Source Type: research